Free Trial
NASDAQ:OLMA

Olema Pharmaceuticals (OLMA) Stock Price, News & Analysis

Olema Pharmaceuticals logo
$4.40 -0.14 (-3.08%)
As of 07/3/2025 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Olema Pharmaceuticals Stock (NASDAQ:OLMA)

Key Stats

Today's Range
$4.45
$4.67
50-Day Range
$4.01
$5.62
52-Week Range
$2.86
$16.62
Volume
210,218 shs
Average Volume
825,907 shs
Market Capitalization
$301.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.50
Consensus Rating
Buy

Company Overview

Olema Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
34th Percentile Overall Score

OLMA MarketRank™: 

Olema Pharmaceuticals scored higher than 34% of companies evaluated by MarketBeat, and ranked 713th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Olema Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Olema Pharmaceuticals has only been the subject of 3 research reports in the past 90 days.

  • Read more about Olema Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for Olema Pharmaceuticals are expected to decrease in the coming year, from ($2.33) to ($2.62) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Olema Pharmaceuticals is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Olema Pharmaceuticals is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Olema Pharmaceuticals has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Olema Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    11.71% of the float of Olema Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Olema Pharmaceuticals has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Olema Pharmaceuticals has recently increased by 6.35%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Olema Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Olema Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.71% of the float of Olema Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Olema Pharmaceuticals has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Olema Pharmaceuticals has recently increased by 6.35%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Olema Pharmaceuticals this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Olema Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    16.36% of the stock of Olema Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    91.78% of the stock of Olema Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Olema Pharmaceuticals' insider trading history.
Receive OLMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

OLMA Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
See More Headlines

OLMA Stock Analysis - Frequently Asked Questions

Olema Pharmaceuticals' stock was trading at $5.83 at the start of the year. Since then, OLMA shares have decreased by 24.5% and is now trading at $4.40.

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.49) by $0.13.

Olema Pharmaceuticals (OLMA) raised $170 million in an initial public offering on Thursday, November 19th 2020. The company issued 10,000,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Jefferies, Cowen and Canaccord Genuity served as the underwriters for the IPO.

Shares of OLMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Olema Pharmaceuticals investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), e.l.f. Beauty (ELF) and Jabil (JBL).

Company Calendar

Last Earnings
5/13/2025
Today
7/07/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:OLMA
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.50
High Stock Price Target
$30.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+456.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$129.47 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$7.14 per share
Price / Book
0.62

Miscellaneous

Free Float
57,227,000
Market Cap
$301.05 million
Optionable
Optionable
Beta
1.90
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:OLMA) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners